Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)

作者： George M. Solomon1, Inez Bronsveld2, Kathryn Hayes3, Michael Wilschanski4, Paola Melotti5, Steven M. Rowe1, Isabelle Sermet-Gaudelus6,7 1Department of Medicine and the Gregory Fleming James Cystic Fibrosis Center,University of Alabama at Birmingham, 2Department of Pulmonology and Tuberculosis,University Medical Center Utrecht, 3Center for Experimental Medicine,Queens University, Northern Ireland, 4Hadassah Hebrew University Medical Center, Jerusalem, 5Centro Fibrosi Cistica,Azienda Ospedaliera Universitaria Integrata, 6Service de Pneumologie et Allergologie Pédiatriques and Center de Ressources et de Compétence de la Mucoviscidose,Hôpital Necker Enfants Malades, 7INSERM U 1151,Institut Necker Enfants Malades

简介：

Overview

This article presents a standardized protocol for measuring nasal potential difference (NPD), which evaluates the function of CFTR and ENaC channels. The method assesses changes in voltage across the nasal epithelium in response to specific solutions, providing insights into ion channel activity.

Key Study Components

Area of Science

• Cystic fibrosis research
• Ion transport mechanisms
• Respiratory physiology

Background

• The nasal potential difference (NPD) is a key measure in assessing CFTR function.
• Understanding ion transport is crucial for developing therapies for cystic fibrosis.
• This method can also be applied to other conditions involving epithelial sodium channel dysfunction.
• Previous studies have shown variable responses in CF patients to CFTR modulation.

Purpose of Study

• To provide a reliable protocol for measuring NPD in research settings.
• To evaluate the coordinated activity of CFTR and ENaC in airway epithelium.
• To explore the potential of this method in other disease systems.

Methods Used

• Superfusion of solutions that modify ion channel activity.
• Measurement of voltage changes across the nasal epithelium.
• Standardization of the NPD measurement protocol.
• Evaluation of patient responses to CFTR activation.

Main Results

• The method effectively measures the function of CFTR and ENaC.
• It provides insights into the ion transport capabilities of CF patients.
• Results indicate variability in responses to CFTR activation.
• The technique shows promise for application in other genetic disorders.

Conclusions

• This standardized protocol is a valuable tool for CF research.
• It enhances understanding of ion transport in cystic fibrosis.
• The method's applicability to other diseases could broaden its impact.

Frequently Asked Questions